JPMorgan Healthcare Lead ETFJDOCETF
13F holders, Q2 2026 (June 30)6holders −3
0new positions
3sold out
1famous investor
$60.62avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding JPMorgan Healthcare Lead ETF (JDOC) in their 13F filings, down 3 from Q1 2026. 0 opened new positions and 3 sold out. The largest holders were JPMorgan Chase & Co. ($5.4M), Citadel Advisors ($449K) and Krilogy Financial LLC ($267K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- JPMorgan Healthcare Lead ETF
- CUSIP
- 46654Q765
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $984K |
All 13F filers, Q1 2026 → Q2 2026: 32,556 shares sold, net −32,556 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| JPMorgan Chase & Co. | 0.00% | No change | 88,196 | $5.4M |
| Citadel Advisors | 0.00% | Reduce -63.5% | 7,460 | $449K |
| Krilogy Financial LLC | 0.01% | Reduce -20.6% | 4,427 | $267K |
| Sanctuary Advisors, LLC | 0.00% | Reduce -15.1% | 4,152 | $250K |
| Royal Bank of Canada | 0.00% | No change | 120 | $7K |
| Wells Fargo & Company | 0.00% | No change | 106 | $6K |
"% of holder's portfolio" is JDOC's weight in each manager's 13F, not the share of JPMorgan Healthcare Lead ETF the manager owns.